Amphetamine Dose‐Dependently Decreases and Increases Binge Intake of Fat and Sucrose Independent of Sex
Objective Amphetamine was formerly used as a treatment to combat obesity, but amphetamine’s use as an appetite suppressant was discontinued because of its significant abuse potential. Most of the rewarding and reinforcing effects of amphetamine differ by sex, with females showing higher levels of dr...
Gespeichert in:
Veröffentlicht in: | Obesity (Silver Spring, Md.) Md.), 2019-11, Vol.27 (11), p.1874-1882 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective
Amphetamine was formerly used as a treatment to combat obesity, but amphetamine’s use as an appetite suppressant was discontinued because of its significant abuse potential. Most of the rewarding and reinforcing effects of amphetamine differ by sex, with females showing higher levels of drug intake and amphetamine‐induced motivation, relapse, and locomotion, but it is unknown whether amphetamine’s effects on feeding also differ by sex. Furthermore, previous research on the anorectic effects of amphetamine has been focused primarily on its effects on baseline homeostatic feeding, but it is unknown whether amphetamine also affects hedonic, reward‐related feeding, which is an important factor driving the rise in obesity levels.
Methods
This study tested whether amphetamine alters food intake in a sex‐dependent manner in two reward‐related feeding paradigms: a sucrose two‐bottle choice test and a high‐fat/high‐sugar binge intake model.
Results
Amphetamine altered food intake equally in males and females in both paradigms, with higher doses significantly inhibiting feeding and low doses of amphetamine increasing feeding at later time points.
Conclusions
Amphetamine’s effects on feeding and drug reward may be mediated by distinct mechanisms, which could allow for the development of new approaches to combat obesity with limited abuse and addiction‐related side effects. |
---|---|
ISSN: | 1930-7381 1930-739X |
DOI: | 10.1002/oby.22636 |